As per a report published by the National Institutes of Health (NIH), approximately 12 million adults are suffering from chronic obstructive pulmonary disease (COPD) in the U.S. Also, COPD is the cause of 12, 000 death annually. Also, as per statistics provided by the Global Asthma Network (GAN), approximately 334 million have been diagnosed with asthma across the globe.
These diseases require oxygen therapy as a part of treatment process. Hence, oxygen therapy devices market is witnessing tremendous demand.
Further, with emergence of the technologically advanced oxygen source devices and deliver devices, the oxygen therapy devices market is likely to expand. Some of the advancements observed in the market are sensor powered delivery devices, pulse dose meters, and regulating devices.
Adoption rate of O2 therapy is rising. This is due to potential benefits offered such as efficient dosing, greater durability, controlled flow, quick response rate, and greater durability & reliability. These factors are likely to propel growth of industry in coming years.
Registering the requirement of customer, the players are consistently bringing innovation in product to serve various purposes. For example, Portable Oxygen Concentrators (POC) are used for wide range of applications such as emergency medicine. It is also used in case of clinical urgency as it is portable. This segment may contribute to growth of oxygen therapy devices market.
With introduction of new products in the market, the units are getting cheaper. As a result, consumer base is widening.
To improve healthcare facilities, hospitals are implementing advanced equipment for diagnosis and therapeutics purpose. Thus, O2 therapy device is also being wide adopted widely.
As per research analysts, hospital segment is likely to contribute to the global oxygen therapy devices market.
North America Oxygen Therapy Devices Market: Snapshot
The North America market for oxygen therapy devices is expanding at a healthy pace and is expected to tread along a healthy growth path in the next few years. Factors such as the rising prevalence of a number of respiratory conditions in the region, such as asthma, COPD, obstructive sleep apnea, and respiratory distress syndrome, are key to the increased demand for oxygen therapy devices in the region. Moreover, the increased demand for effective home healthcare services and the rapid pace of technological advancement are also working in favor of the market.
The report estimates that the North America oxygen therapy devices market will rise to a revenue opportunity of US$1.58 bn by 2023, registering a CAGR of 5.5% between 2015 and 2023.
Rising Demand for Venturi Masks to Fuel Market Growth
On the basis of product, the report segments the North America oxygen therapy devices market into oxygen source equipment and oxygen delivery devices. The report further analyzes the segment of oxygen delivery devices for varieties such as nasal cannula, bag valve masks, non-rebreather masks, venturi masks, simple oxygen masks, and CPAP (continuous positive airway pressure) masks. Of these, the segment of venturi masks is expected to expand at a CAGR of over 7% over the report’s forecast period. Factors such as minimum discomfort along with high accuracy work in favor of the segment.
The segment of oxygen source equipment is further analyzed for varieties such as liquid oxygen devices, oxygen cylinders, and oxygen concentrators. Of these, the segment of oxygen concentrators presently holds the dominant revenue share in the overall market. Over the forecast period, however, the segment of liquid oxygen devices will expand at the maximum CAGR, thanks to benefits such as ease of carrying, ease of use, better storage capacity, energy efficiency, low cost per unit, and maximum mobility.
High Prevalence of COPD to Maintain U.S.’s Positions as Dominant Regional Market
From a geographical perspective, the report covers the North America oxygen therapy devices market for the U.S. and Canada. Of these, the market in the U.S. is expected to account for a massive chunk in revenue of the overall market throughout the report’s forecast period. The rising population of people with COPD in the country will chiefly lead to the scenario; COPD is considered the third leading causes of death in the country, with nearly 11 mn people in the country diagnosed with the country in 2013. The U.S. market for oxygen therapy devices will continue to expand at a prominent pace over the forecast period as well, thanks to the increased level of awareness regarding available treatments for a number of chronic respiratory conditions.
The rising uptake of technologically advanced devices in the country’s healthcare infrastructure, driven chiefly by the several encouraging initiatives such as National Asthma Control Initiative (NACI) undertaken by the government. Nevertheless, the market in Canada is also expected to register a noteworthy CAGR over the forecast period, chiefly owing to the rising population of geriatrics and the rising prevalence of a variety of respiratory diseases in the country.
Some of the leading companies operating in the North America oxygen therapy devices market are Fisher & Paykel Healthcare Limited, Teleflex Incorporated, MAQUET Holding B.V. & Co. KG, Philips Respironics Inc., CareFusion Corporation, Invacare Corporation, Smiths Medical, AirSep Corporation, and DeVilbiss Healthcare LLC.
Interested in this report?
Get a FREE sample now!
*Get Sample Report (PDF) sent to your email within minutes
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology
2. Executive Summary
2.1. North America Oxygen Therapy Devices: Market Snapshot
2.2. Market Share, by Application, 2014 (US$ Mn)
2.3. Market Share, by Product Type, 2014 (US$ Mn)
3. Industry Analysis : North America Oxygen Therapy Devices
3.1. Introduction and Market Definition
3.2.1. Rise in incidence of COPD and other respiratory diseases
3.2.2. Increasing patient preference for portable home oxygen therapy equipment
3.3.1. Patient concerns associated with complication of long-term oxygen therapy
3.4.1. Technological advancements in the field of respiratory care to spur market growth
3.4.2. Increasing government initiatives toward improving respiratory care
3.5. Porter’s Five Forces Analysis
3.6. Market Attractiveness Analysis
3.6.1. North America Oxygen Therapy Devices Market, by Product Type
3.6.2. Market, by Country
3.7. Prescription Analysis
3.8. Competitive Landscape
3.8.1. Market Share, by Key Players, 2014
3.8.2. Brand Positioning Maps: North America Oxygen Delivery Devices
3.8.3. Brand Positioning Maps: North America Oxygen Source Equipment
3.9. Economic Outlook & Geopolitical Analysis
3.10. Reimbursement Policies
4. Market Segmentation – By Product Type
4.2. Market Revenue, by Product Type, 2013–2023 (US$ Mn)
4.3. North America Oxygen Source Equipment, By Type, 2013–2023 (US$ Mn)
4.3.1. North America Oxygen Cylinders Market Revenue, by Country, 2013–2023, (US$ Mn)
4.3.2. North America Oxygen Concentrators Market Revenue, by Country, 2013–2023, (US$ Mn)
4.3.3. North America Liquid Oxygen Devices Market Revenue, by Country, 2013–2023, (US$ Mn)
4.4. North America Oxygen Delivery Devices, By Type, 2013–2023, (US$ Mn)
4.4.1. North America Simple Oxygen Mask Revenue, by Country, 2013–2023, (US$ Mn)
4.4.2. North America Venturi Mask Market Revenue, by Country, 2013–2023, (US$ Mn)
4.4.3. North America Nasal Cannula Market Revenue, by Country, 2013–2023 (US$ Mn)
4.4.4. North America Non-Rebreather Market Revenue, by Country, 2013–2023 (US$ Mn)
4.4.5. North America Bag Valve Mask Market Revenue, by Country, 2013–2023, (US$ Mn)
4.4.6. North America CPAP Mask Market Revenue, by Country, 2013–2023, (US$ Mn)
5. Market Segmentation – By Application
5.2. North America Oxygen Therapy Devices Market Revenue, by Application, 2013–2023 (US$ Mn)
5.2.1. Market Revenue in COPD, 2013–2023 (US$ Mn) and Analysis
5.2.2. Market Revenue in Asthma, 2013–2023 (US$ Mn) and Analysis
5.2.3. Market Revenue in Obstructive Sleep Apnea, 2013–2023 (US$ Mn) and Analysis
5.2.4. North America Oxygen Therapy Devices Market Revenue in Respiratory Distress Syndrome, 2013–2023 (US$ Mn) and Analysis
5.2.5. Market Revenue in Cystic Fibrosis, 2013–2023 (US$ Mn) and Analysis
5.2.6. North America Oxygen Therapy Devices Market Revenue in Pneumonia, 2013–2023 (US$ Mn) and Analysis
7. Company Profiles
7.1. Chart Industries (AirSep Corporation)
7.2. CareFusion Corporation
7.3. DeVilbiss Healthcare LLC
7.4. Fisher & Paykel Healthcare Limited
7.5. Invacare Corporation
7.6. MAQUET Holding B.V. & Co. KG.
7.7. Koninklijke Philips N.V.
7.9. Smiths Medical
7.10. Teleflex Incorporated
Complete the form below and we'll get back to you shortly.